Idorsia
Idorsia slashes 300 jobs in R&D amid cost-cutting efforts
Anika Sharma
The company has announced that it will be reducing its workforce by 300 individuals, with a focus on R&D and ...
J&J Gives Up On $230M Blood Pressure Drug After Disappointing Trial Results
Anika Sharma
Johnson & Johnson (J&J) is stepping back from its $230 million investment in a blood pressure treatment, aprocitentan, and returning ...
In a $466 million agreement, Sosei acquires the Japan and Korea subsidiaries of Idorsia
SG Tylor
Source – Sosei Heptares Japan’s Sosei Group has successfully transformed into a commercial-stage pharmaceutical company by acquiring the rights to ...
